HYTN Introduces HARd Remediation to GMP Processing Services, Releases Product in Germany

VANCOUVER, British Columbia, April 17, 2026 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC Pink: HYTNF) (“HYTN” or the “Company”), a pharmaceutical manufacturer specializing in products containing psychoactive and psychotropic compounds, is pleased to announce the commercial launch of Hermetic Autogenous Remediation (“HARd”) as a service offering for qualified dried cannabis flower programs.

HARd is HYTN’s proprietary remediation process for dried cannabis flower, developed and validated within the Company’s GMP quality systems. The process is designed to reduce microbial burden while preserving the structural, organoleptic and chemical characteristics of dried cannabis flower.

According to the Company’s validation work and third-party analytical testing, HARd has demonstrated significant microbial reduction across evaluated cannabis cultivars, including multi-log reductions in Total Aerobic Microbial Count, Total Yeasts and Moulds Count, and Bile-Tolerant Gram-Negative organisms. In many evaluated cases, post-process findings were reported at levels intended to support qualification against stringent microbiological specifications associated with inhalation drug specifications under the European Pharmacopoeia.

The Company notes that HARd does not rely on external thermal input, ionizing or non-ionizing radiation, chemical fumigation, or dehydration-based remediation methods. HYTN believes these process characteristics are relevant for counterparties seeking a remediation pathway intended to support product quality while maintaining key physical and chemical attributes within tightly controlled quality and regulatory frameworks, including EU-GMP-aligned programs.

The Company further notes that dried cannabis flower processed using HARd has now been released in Germany under a commercial program, demonstrating the practical application of the process within a regulated international supply context. While that product release should not be interpreted as regulatory approval of HARd as a methodology, it does demonstrate the process has been applied in a commercial setting.

HYTN intends to offer HARd as a service to domestic and international counterparties seeking a remediation solution developed within an EU-GMP-aligned quality framework. The Company notes that HARd is best described as a proprietary process developed and validated within such a framework and should not be interpreted as an independently certified system or as regulatory approval of the methodology itself. The Company believes this service offering complements its broader GMP processing and international market development activities, including activities in Germany, the United Kingdom and Australia.